Concordant with the immunomodulation observed in blood, there was an elevation in the percentage of splenic CD3+ T cells, accompanied by a reduction in CD19+ B cells after tumor transplant, and the increase in the splenic T cells was dominantly contributed by CD8+ T cells that exhibited an effector memory phenotype (Figure S3A–E). Here, CD19 is linked to neoplasm.